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Some Historical Aspects of N*AryI
Carcinogens and Their Metabolic
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by James A. Miller* and Elizabeth C. Miller*
This limited review of the early studies on the activation of theN-aryl carcinogens was written to
provide a background for the current research to be presented at this conference on carcinogenesis
by N-aryl compounds. Since the work of the past 10 years is too recent to be judged in a historical
sense and because those data are much better known by current investigators, this review is gener-
ally limited to data up to 1972.
Discovery of N-Aryl Carcinogens
As for all history, the events of each period are
rooted in the events of earlier times. Thus, the cur-
rent interest in the carcinogenic activities of the N-
aryl compounds can be traced to developments in
organic chemistry in the mid-nineteenth century (1)
(Table 1). The discoveries of Runge, Perkins,
Verguin and Griess laid the foundations of the
synthetic dyestuffs industry of Germany, which
within a few decades had developed to such
proportions that it was serving all of the industrial
world. These dyes were generally based on
aromatic amines or products made from aromatic
amines, and accordingly their production
necessitated the manufacture of these amines in
Table 1. The origins of synthetic dyes derived from
aromatic amines.
Year Author
1840 Runge
1856 Perkins
1859 Verguin
1858 Griess
1864 Griess
1860s
Synthesis of aniline blacks
(quinonediimine complexes)
Synthesis of mauve (a phenazine)
Synthesis of fuchsin (a triphenylmethane
dye)
Diazotization of aromatic amines
Azo dyes from coupling of diazonium salts
with aromatic amines and phenols
Start of German synthetic dyestuffs
industry and its role as a world supplier of
dyes
*McArdle Laboratory for Cancer Research, University of
Wisconsin Medical School, Madison, WI 53706.
large amounts. At first, the knowledge of their toxic
effects was limited, and the need for protection of
the work force and conditions suitable for this
protection were not appreciated or generally
available.
Subsequent events, starting with the classical
clinical report of Rehn (2) in 1895 on the occurrence
of urinary bladder cancer in 3 of 45 workers en-
gaged in the manufacture of fuchsin from crude aro-
matic amines for 15-29 yeats, demonstrated the del-
eterious effects of the prolonged exposures to these
aromatic amines. Rehn's understanding of the prob-
lem is reflected in the following translation of a por-
tion of his paper:
"For the majority of bladder cancers one can only imag-
ine that substances were present in solution in the
urine ... and that these caused a tumor to form by
means of a chemical stimulus... For the time being
these substances completely escape our knowledge.
I am going to tell you about a number of illnesses
which, with a high degree of probability, can be attrib-
uted to a chemical stimulus."
The various illnesses, in addition to bladder can-
cer, included hematuria, cyanosis and involuntary
urination. By 1908, Rehn had reported 56 cases of
urinary bladder cancer in workmen from seven dye
factories in the area around Frankfurt, Germany,
and as early as 1898 Leichtenstern (4) pointed to 2-
naphthylamine as a possible cause. Occupational uri-
nary bladder cancer from gross exposures to sev-
eral aromatic amines occurred in over a dozen coun-
tries after 1900, especially after World War I (O).
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experimental mammal was established in 1938 by
Hueper et al. (5), who obtained benign and malig-
nant tumors of the urinary bladder in 13 of 16 dogs
administered the compound for 20-26 months. This
observation was followed within a few years by
data on the carcinogenic activities in rodent tissues
of 2-acetylaminofluorene (AAF) (6), 4-aminostilbene
(7), benzidine (8), N,N-dimethyl4-aminobiphenyl (9)
and 3-acetylaminodibenzothiophene (9). Subse-
quently the carcinogenicities of a variety ofotherN-
aryl compounds, including heterocycic derivatives,
were observed (10).
A parallel series of findings led to demonstrations
of the carcinogenicities of certain aminoazo dyes re-
lated to 4-aminoazobenzene (AB) (Fig. 1). Thus, in
1906, Fischer (11) observed that Scarlet Red caused
a strong, but reversible, hyperplastic reaction in
rabbit skin epithelium. These results were applied
to clinical problems and between 1908 and 1911 sev-
eral papers were published that demonstrated the
clinical efficacy of Scarlet Red and o-aminoazotol-
uene (2',3-dimethyl-4-aminoazobenzene) in promoting
the healing of refractory skin lesions in the human
(12). Adenomatous growths were observed by
Schmidt (13) in the livers of mice fed Scarlet Red,
and in the mid-1930s Yoshida and Sasaki (14, 15) and
Kinosita (16, 17) reported the strong hepatocarcino-
genic activities in rats of o-aminoazotoluene and
N,N-dimethyl-4-aminoazobenzene (DAB), respective-
ly.
1906 FISCHER
1908- SCHMIEDEN
1911 AND OTHERS
1924 SCHMIDT
Protein Binding in Relation to the
Carcinogenicity of Some
Aminoazo Dyes
Against this background Rusch and Baumann at
the University of Wisconsin initiated a series of
studies on the effects of diet on carcinogenesis by
DAB and other compounds in the 1940s. As collabo-
rators in these nutritional studies (18) we developed
an interest in the mechanisms of action of DAB as a
hepatic carcinogen. The data of Stevenson et al. (19)
in 1942 on the urinary excretion of high yields ofN-
acetyl-p-aminophenol andN,N'-diacetyl-p-phenylene-
diamine by rats fed this dye demonstrated that the
carcinogen and its metabolites underwent reduction
of the azo linkage, N-demethylation, and ring
hydroxylation in unidentified sequences. Prelim-
inary data by Kinosita (17) suggested that these
monophenyl metabolites were not carcinogenic.
In addition to its carcinogenic activity, DAB had
other properties that made it an especially good
candidate for study during that period of biochemi-
cal science. One advantage was the relative ease of
synthesis of DAB and its congeners. Of great impor-
tance in that period before l'C and 3H were available
for laboratory studies were the acid-base indicator
properties of DAB and its high molar extinction co-
efficients (t,,a = 27,400 at 410 nm in ethanol and
Emax = 42,800 at 518 nm in 4N HCl). The yellow dye
was readily extractable from organic solutions into
SCARLET RED,
AS A HYPERPLASTIC AGENT IN RABBIT SKIN EPITHELIUM
BEGINNING OF CLINICAL USE OF SCARLET RED AND
o-AMINOAZOTOLUENE (2',3-DIMETHYL-4-AMINOAZOBENZENE)
TO ACCELERATE WOUND HEALING
ADENOMATOUS GROWTHS IN LIVERS OF MICE FED SCARLET
RED
1933 YOSHIDA LIVER CARCINOMAS IN RATS FED o-AMINOAZOTOLUENE,
1935 SASAKI AND CH3
YOSH IDA
1936 KINOSITA N,N-DIMETHYL-4-AMINOAZOBENZENE,
(N=N* Nif
AS A STRONG HEPATOCARCINOGEN IN THE RAT
FIGURE 1. Early observations on the hyperplastic and carcinogenic activities of aminoazo dyes (11-17).
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strong HCl, and the color intensity of the reddish-
pink acidic solution was sufficient for detection of as
little as 1 lAg of the dye, even with the simple photo-
electric filter colorimeters then available. It might
be noted parenthetically that, in the early 1940s,
Beckman or similar spectrophotometers were not
available, visible absorption spectra were obtainable
only with visual comparators, and data on ultravio-
let spectra were obtained only by cumbersome pho-
tographic technics.
Our first studies, directed toward the determina-
tion of the "free" dyes in the liver, showed the oc-
currence of low levels of DAB,N-methyl-4-aminoazo-
benzene (MAB), and AB in the livers of rats fed
DAB or MAB. Only AB was detected in the livers
of rats fed this noncarcinogenic dye (20, 21). Assays
soon showed that MAB and DAB had approxi-
mately equal carcinogenic activities in rat liver (22),
while all of the other known metabolites of DAB
were essentially inactive whether tested individ-
ually or as mixtures (22, 23). In the course of these
studies, other dyes were found associated with the
liver protein (24). Thus, the protein from perfused
livers of DAB- or MAB-fed rats showed the acid-
base indicator properties noted above for DAB.
Since the dye could not be removed from the pro-
tein by procedures that did not involve hydrolysis
of the protein and since the dye liberated by hydro-
lysis was much more polar than DAB or MAB, it
was concluded that the protein-associated dye was
covalently bound. These data thus pointed to the
metabolism of DAB or a derivative to a chemically
reactive form. Early correlations between the
amounts of the protein-bound dye in the livers of
rats fed a series of dyes, in various tissues of the rat
and other species, and as a function of diet sug-
gested its possible importance in the carcinogenicity
of DAB (24). 2-Methyl-DAB was an early apparent
exception. This dye did not produce tumors but it
became bound to rat liver protein in vivo to the
same level as did DAB (25). Later, 2-methyl-DAB
was found by Warwick (26) and Kitagawa et al. (27)
to be essentially only an initiator of liver tumors.
The above data and the finding that the primary
tumors induced by the dyes had very little or no
bound dye, even with continued administration of
DAB or MAB, provided the basis for a "protein-de-
letion" theory of carcinogenesis (24). This theory re-
ceived support from the finding with Sorof and Co-
hen (28) that the protein-bound dye was rather spe-
cifically associated with electrophoretically identifi-
able "h" proteins and from the data of Sorof and Co-
hen (29) that these proteins were present at only
very low levels in the primary hepatic carcinomas
induced by the dye. This protein-deletion hypothesis
now appears to have only historical importance.
Younger investigators may have little appreciation
of the much better understanding in the 1940s of
the biological activities of the proteins as compared
to the understanding of the functions of the nucleic
acids. Thus, the classical studies of Avery and his
colleagues (30) on the ability of bacterial DNA to
transform bacteria of one type to another type were
first reported in 1944, and a number of years
elapsed, even after the seminal paper of Watson
and Crick in 1953 (31), before DNA was generally
recognized as the basic information-containing mole-
cule of the cell. Furthermore, while our limited ana-
lytical procedures were adequate to detect the pro-
tein-bound dyes, this was not the case for the nu-
cleic acid-bound derivatives discovered later. Mixed
nucleic acids isolated from the livers of dye-fed rats
showed no pink color in acid (32). As became evident
from later studies (33, 34), the structure of the ma-
jor nucleic acid-bound derivative of DAB and MAB
did not permit the resonance structure responsible
for the distinctive red color of the dyes under acidic
conditions.
From 1950 to 1962 we made repeated attempts to
determine the structures of the protein-bound de-
rivatives of DAB and related prime-ring-methylated
dyes. By reduction of the azo linkage and steam-dis-
tillation of the resultant aniline or toluidine, we as-
certained that the "prime" ring was apparently not
involved in the linkage to protein (25). Accordingly,
the presumed linkages to the amino acid residues
were ascribed to the "diamine" ring or the nitrogen
atom, and these sites of binding were documented
later by Scribner et al. (35) and by Lin et al. (3&38)
on characterization of the methionine, homocys-
teine, and tyrosine adducts. However, the structural
studies were greatly hampered by the relatively
small amounts (about 50 ,ug/liver), by the lack of any
model reactive carcinogen derivative, and by the
relatively limited state of the separation and or-
ganic characterization sciences as compared with
those that soon became available.
The possible relevance of protein-bound forms of
the aminoazo dyes to their carcinogenic activities
seemed great enough to warrant similar studies
with other carcinogens. Within a few years a num-
ber of investigators had found protein-bound deriva-
tives of two carcinogenic polycyclic aromatic hydro-
carbons, of ethionine, and of AAF in the target tis-
sues (S3 39-42) (Table 2). The advent of 14C-labeled
carcinogens, first used by Heidelberger and Jones
(43) in 1948, greatly facilitated the studies on pro-
tein-bound carcinogen derivatives and, probably
more importantly, made possible similar searches
for nucleic acid-bound carcinogen derivatives. Thus,
nucleic acid-bound derivatives of the N- and S-
mustards, dimethylnitrosamine, ethionine, AAF,
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Table 2. Early findings on the covalent binding of carcinogens
to proteins and nucleic acids in vivo.
Carcinogen
Protein-bound carcinogens
DAB
Benzo(a)pyrene
Ethionine
AAF
Dibenz(a,h)anthracene
Nucleic acid-bound carcinogens
Nitrogen mustard
Sulfur mustard
Dimethylnitrosamine
Ethionine
AAF
DAB
Polycyclic aromatic
hydrocarbons
Investigators
Miller and Miller (1947)
Miller (1951)
Levine and Tarver (1951)
Miller and Miller (1952);
Weisburger et al. (1953)
Wiest and Heidelberger (1952)
Wheeler and Skipper (1957)
Brookes and Lawley (1960)
Farber and Magee (1960)
Farber and Magee (1960)
Marroquin and Farber (1962)
Marroquin and Farber (1963)
Brookes and Lawley (1964);
Heidelberger (1964)
DAB, and several polycyclic aromatic hydrocarbons
were reported between 1957 and 1964 (44.50) (Table
2). However, none of the protein- or nucleic acid-
bound derivatives of the carcinogens were charac-
terized at that time.
Metabolic Activation of In Vivo of
2-Acetylaminofluorene by
N Hydroxylation
The studies on the metabolism and carcinogenic-
ity of the aromatic amines in Britain during the late
1940s and the early 1950s were directed primarily
to the naphthylamines and the 4-aminobiphenyl de-
rivatives and emphasized particularly the induction
of cancer of the urinary bladder (10, 51, 52). This em-
phasis resulted in the development by Bonser and
his colleagues (51) of an assay for urinary bladder
carcinogens which depended on the luminal implan-
tation in mouse bladders of pellets of cholesterol or
wax containing the test compound. Their finding
that a number of o-hydroxyamine metabolites in-
duced urinary bladder tumors in this assay sug-
gested to Clayson and his colleagues (51, 53) that o-
hydroxyamines might be critical metabolites in aro-
matic amine carcinogenesis.
During this same period the Weisburgers and
their colleagues (54) examined in considerable detail
the urinary metabolites of AAF in the rat. They
demonstrated that metabolic hydroxylation of the
rings occurred at the 1, 3, 5, 6, 7 and 8 positions, in-
cluding the two positions (1 and 3) ortho to the nitro-
gen atom. Furthermore, on the basis of the initial
studies of Richardson et al. (55), the simultaneous
administration of 3-methylcholanthrene or of certain
other planar polycyclic aromatic hydrocarbons with
3'-methyl-DAB or AAF was found to inhibit the car-
cinogenicities of these amine and amide carcinogens
(5&58). As an approach to probing the possible sig-
nificance of the ortho-hydroxy derivatives of AAF
to carcinogenesis by this compound, Cramer and we
(59, 60) examined the urinary excretion of AAF me-
tabolites when the AAF was fed to rats alone or
simultaneously with 3-methylcholanthrene. A fortu-
nate and unexpected result of this experiment was
the detection of a new urinary metabolite of AAF,
the amount of which gradually increased to about
15% of the dose after 18 weeks of administration of
AAF in rats expected to develop liver tumors by 6
months. Much smaller amounts were excreted by
rats in which the hepatocarcinogenicity of the AAF
was greatly inhibited by administration of 3-
methylcholanthrene.
Although a new metabolite of a xenobiotic com-
pound may be of disappointingly low interest if its
identification demonstrates only one more detoxifi-
cation route, characterization of this metabolite of
AAF provided a new focus in the understanding of
the metabolic activation of aromatic amine and
amide carcinogens and of the toxicity of aromatic
amines and amides in general. The new metabolite
was isolated and characterized as a conjugate (pre-
sumably the glucuronide, since it was cleaved by
crude (3-glucuronidase) of N-hydroxy-AAF (59). The
structure of this metabolite was deduced from its
acidic character, its elementary analysis (only the
addition of one oxygen atom to the elementary for-
mula of AAF), and its separability from all of the
ring-hydroxy derivatives of AAF, most of which
had been prepared and studied by the Weisburgers.
An unequivocal synthesis of N-hydroxy-AAF from
2-nitrofluorene and demonstration of the identity of
the synthetic and metabolic products provided de-
finitive evidence for the structure of the metabolite
(59). Since, on administration, N-hydroxy-AAF
proved to be more active as a carcinogen than AAF
in a number of rat tissues and in a number of spe-
cies (61, 62), N-hydroxy-AAF was thus identified as
a proximate carcinogenic metabolite of AAF. This
was the first recognition of a proximate carcino-
genic metabolite. Subsequent studies with a variety
of aromatic amines and amides have strongly impli-
cated N-hydroxylation as a first step in their activa-
tion for carcinogenic activity (63). At the present
time there appears to be no exception to the gener-
ality that aromatic amine and amide carcinogens
are N-hydroxylated as the first stage in their meta-
bolic activation to reactive electrophiles, although
oxidation to free radicals, early suggested as an al-
ternative pathway (64.67), requires further investi-
gation.
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Discovery of Metabolically Derived
Electrophilic N,ODerivatives
The concept of the electrophilicity of reactive
forms of chemical carcinogens was curiously slow in
developing in studies on chemical carcinogenesis.
Although by the early 1950s a number of alkylating
agents were shown to have carcinogenic activity
(68), their activities were relatively weak and these
carcinogens received only limited study. To our
knowledge the alkylating agents were not regarded
as prototypes for the reactive forms of chemical car-
cinogens in general. The concept of electrophilic re-
activity as a feature of the activities of other chemi-
cal carcinogens was forced on workers in the field
by direct observations, and the first of these were
made with the N-aryl carcinogens. Thus, the activa-
tion of hydroxylamines by protonation, already
known to the organic chemists, was applied toN-hy-
droxy-AF by Kriek (69), who demonstrated its acid-
catalyzed reaction with guanine residues in nucleic
acids in 1965. That formation of N-hydroxy-AF was
a metabolic possibility was demonstrated the next
year by Irving (70). The degree of protonation at
physiological pH of most aromatic hydroxylamines
is relatively low, and the significance of these pro-
ton-catalyzed reactions of aromatic hydroxylamines
in amine carcinogenesis requires further study.
Also in the mid-1960s a reinvestigation of the
"free" dyes from the. livers of rats fed DAB pro-
N-BENZOYLOXY-MAB
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]
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+ TYROSINE
vided unexpected insight into the structures and de-
rivation of the bound dyes. Scribner et al. (35) found
that what was termed DAB from the liver was ac-
tually a mixture of DAB and another dye, which
arose from decomposition of a protein-bound dye.
This new dye was characterized as 3-methylmer-
capto-MAB and was deduced to be derived from
protein-bound 3-methion-S-yl-MAB residues. About
the same time Poirier, unable to synthesize N-hy-
droxy-MAB, synthesized its benzoic acid ester (71);
we hoped that administration ofN-benzoyloxy-MAB
would result in liberation of N-hydroxy-MAB in
vivo. However, N-benzoyloxy-MAB proved to be an
electrophilic reactant at neutrality, and on incu-
bation with methionine it yielded a polar dye that
decomposed to 3-methylmercapto-MAB (71, 72) (Fig.
2). Analogous studies with N-acetoxy-AAF showed
that it had similar, but stronger, electrophilic reac-
tivity. Thus, N-acetoxy-AAF reacted at neutrality
with methionine to yield 1- and 3-methylmercapto-
AAF (72) and with guanine residues in nucleosides
or polynucleotides (73, 74); under appropriate condi-
tions nearly all of the guanine residues in DNA or
RNA could be modified. N-Benzoyloxy-MAB and N-
acetoxy-AAF proved to be carcinogenic in the sub-
cutaneous tissue of rats, a site where the respective
parent compounds MAB and AAF did not produce
tumors (71, 75).
Further studies emphasized the possible impor-
tance of the reactivity of the electrophilic esters of
RAT LIVER IN VIVO
MAB
O-N, ND-NcH
REACTIVE METABOLITES
PROTEIN-, RNA-,AND DNA-BOUD FORMS
(,HYDROLYSIS
+ (DEOXY)GUANOSINE
FIGURE 2. Nonenzymatic reactions at neutrality ofN-benzoyloxy-MAB with methionine, cysteine, tyrosine, homocysteine, guano-
sine and deoxyguanosine. Cochromatography showed that the adducts formed in these reactions are identical to derivatives
obtained from the liver protein or nucleic acids of rats administered MAB.
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N-hydroxy-MAB and N-hydroxy-AAF in relation to
the biological activities of MAB and AAF or N-hy-
droxy-AAF. Thus, by analogy to the finding of 3-
methylmercapto-MAB as a degradation product of
the protein-bound dyes from DAB and MAB (35, 71),
1- and 3-methylmercapto-AAF were obtained on de-
gradation of the liver proteins from rats fed N-hy-
droxy-AAF (76). Homocysteinyl and tyrosinyl deriv-
atives, which were identical to those synthesized
from the amino acids and N-benzoyloxy-MAB, were
isolated from the livers of rats treated with MAB
(37, 38). Somewhat later, Ketterer and Christo-
doulides (77, 78) found dye residues linked to cys-
teine residues in ligandin and to methionyl residues
in a fatty acid binding protein in the liver cytosol of
rats fed DAB. Furthermore, major adducts in the
RNA and DNA from rats given AAF orN-hydroxy-
AAF were found to be identical to the N4guan-8ylI
AAF derivatives obtained on reaction of guanosine
or deoxyguanosine with N-acetoxy-AAF (74, 79, 80).
Accordingly, tissue preparations, especially rat liver,
were examined for their abilities to form these reac-
tive esters enzymatically.
Five enzymatic systems for the conversion of N-
hydroxy-AAF to electrophilic reactants had been
demonstrated in rat liver preparations by 1972. The
first of these is the microsomal deacetylation of N-
hydroxy-AAF to N-hydroxy-AF (70), which was
demonstrated by Kriek (69) to undergo an acid-cata-
lyzed reaction with nucleic acid guanine residues
(Fig. 3). The glucuronide of N-hydroxy-AAF, which
is a major metabolite (60, 83, 84), has weak electro-
philic reactivity at neutral pH (85, 86). The extent of
reaction of the glucuronide increases very rapidly
with small increases in pH; this increase in activity
apparently results from loss of the N-acetyl group
and the markedly greater reactivity of the glucuro-
nide of N-hydroxy-AF as compared to that of N-
hydroxy-AAF (87). The next metabolic pathway to
be identified was the sulfotransferase reaction for
the formation of N-sulfonoxy-AAF (88, 89). This es-
ter ofN-hydroxy-AAF is a stronger electrophilic re-
actant than N-acetoxy-AAF, and the sulfotrans-
ferase activity for N-hydroxy-AAF in liver parallels
quite well the susceptibility of the livers of males of
various species or of rat liver under various condi-
tions to carcinogenesis by N-hydroxy-AAF (76).
Shortly thereafter Bartsch et al. (65, 66) observed
that a 1-electron oxidation of N-hydroxy-AAF by
purified peroxidases yielded a free nitroxide radical
which on dismutation gave N-acetoxy-AAF and 2-ni-
trosofluorene. Finally, cytosols from liver and a
wide variety of other tissues carry out an acyl
transferase reaction which, in effect, transfers the
N-acetyl groups of N-hydroxy-AAF or other aro-
matic acethydroxamic acids to the oxygen atoms to
yield N-acetoxyarylamines (90, 91). Yet another
mechanism was demonstrated by Tada and Tada
(92 93), who observed the activation of 4-hydroxy-
aminoquinoline 1-oxide by its esterification with ser-
ine activated by seryl-t-RNA synthetase.
The reactivity of these electrophilic compounds
AA I.2CH3(AC)
N'H
Cyt. P-450-(O)
'~~~"OH
deacetylase, trans- I-electron sufotransferose
H' ocetylase osudation + +PAPS me-lo, dismutation
ELECTROPHILIC +IH +,o *,Ac A
METABOLITES NXr og.A2 %./AC -N'Ac > O-SO3 \ / 1 X HN
0 H
HEPATIC DNA- HNNNH j%N.w + AAC dR
ADDUCTS IN VIVO vtNq NHNI-12 N, NJV+ - H
dR dR
FIGURE 3. Pathways for the metabolism of AAF to electrophilic reactants in rat liver. In addition to the reactions shown, N-hy-
droxy-AAF is also metabolized to its O-glucuronide. The latter metabolite, although a much weaker electrophile, also reacts
with nucleic acids to yield both N-acetylated and nonacetylated adducts. The adducts N4guan-8-yl)-2-aminofluorene and 3-(guan-
N2-yl)-2-acetylaminofluorene were characterized only within the past few years (81, 82). Citations for the other reactions and
structure shown are given in the text.
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FIGURE 4. The mutagenicities of esters of N-hydroxy-AAF
for Bacillus subtilis transforming DNA. The nonelectro-
philic metabolites shown were not mutagenic (94).
with nucleic acids naturally led to the question of
the biological consequences of these reactions. A
suitable test for these very reactive compounds ap-
peared to be one that utilized transforming DNA,
and studies with Maher and Szybalski (94) showed
that esters ofN-hydroxy-AAF and N-hydroxy-MAB
were strong mutagens for BaciUus subtilis trans-
forming DNA (Fig. 4). This first demonstration of
the mutagenicity of ultimate carcinogenic and elec-
trophilic derivatives of carcinogens, together with
the deduction that the ultimate forms of all or most
carcinogens are electrophilic reactants (75, 95), pro-
vided a strong catalyst for the development of mu-
tagenicity assays for the detection of potential car-
cinogens (9&99) and for the provision of metabolic
activating systems in these assays.
Concluding Remarks
Because of the time frame that we have used (i.e.,
data up to 1972), this historical review covers the
period of the recognition of the carcinogenicities of
a variety of aromatic amines and amides and the de-
velopment of the concept that the carcinogenicity of
these compounds depends on the metabolic forma-
tion in vivo of electrophilic reactants that covalently
bind to informational macromolecules in target cells.
The characterizations of the products formed in
cells from the electrophilic metabolites and the bio-
logical consequences of these reactions are more re-
cent areas of study. Current approaches in these
studies are the principal subjects in most of the sub-
sequent chapters of this book.
The current understanding of the separation of
tumor induction in many, and quite possibly all, tis-
sues into stages of initiation and promotion (100)
should facilitate future studies of chemical carcino-
genesis. It is now evident that some chemicals may
be active in only one or the other step and that
many carcinogens may have both activities, but in
different proportions. This clarification of these
qualitatively different biological activities will pre-
sumably make it easier to establish which reactions
are essential to each stage ofcarcinogenesis.
The recent quantum leaps in the molecular
characterization of the retroviruses and of the
conditions which make possible the expression of
the naturally occurring c-onc genes (101) have
provided a new understanding of the expression of
cellular genetic information and new models for the
initiation of carcinogenesis. Whereas much of the
earlier thought on the ability of chemicals to initiate
carcinogenesis centered on the causation of frame-
shift or base-substitution mutations or of major
deletions, these recent observations raise the
question of whether or not chemicals may initiate
carcinogenesis through facilitating genomic
rearrangements that result in the expression of
previously unexpressed c-onc or other genes with
similar potential (102, 103). We may be on the
threshold of major advances in our understanding
of the molecular mechanisms of action of chemical
carcinogens.
The authors' work is supported by Grants CA-07175 and
CA-22484 of the National Cancer Institute, USPHS.
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